Skip to main content

OncoLink

Thank you so much for publishing an article on OncoLink [F. Hoke, The Scientist, April 3, 1995, page 1]. I thought it was a good, balanced report. I believe that a quality future for OncoLink, or OncoLink by another name, will happen only if discussion concerning OncoLink has a good media forum. Thank you for providing such a forum. I don't believe that the present editors of OncoLink understand the dynamics necessary to keep OncoLink current and responsive to patients' needs. They envisioned

Written byLinda Yarger
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00

I believe that a quality future for OncoLink, or OncoLink by another name, will happen only if discussion concerning OncoLink has a good media forum. Thank you for providing such a forum.

I don't believe that the present editors of OncoLink understand the dynamics necessary to keep OncoLink current and responsive to patients' needs. They envisioned themselves primarily as editors or reviewers. Essentially this is a passive role. OncoLink attained its former status because Loren Buhle did not operate in a passive role. By reading Internet Usenet and mailing/discussion lists and by participating in the CompuServe cancer forum, he stayed informed about patients' most urgent concerns. A concept of what material is needed and the dedication to find such material is part of what Buhle provided. In addition, he provided that information in a timely manner.

In my opinion, OncoLink is currently becoming stale. As time goes, I am guessing ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Published In

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo